Monday, December 22, 2025 12/22/2025

Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology

Award Number: R21CA294038
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/19/2024
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology - ABSTRACT The utilization of genetically engineered T-cells containing Chimeric Antigen Receptors (CARs) has demonstrated remarkable efficacy in treating hematologic malignancies. Despite this success, CAR-T cell therapies have encountered challenges in specificity and off-target toxicity when confronting solid tumors. To address these challenges, we propose an innovative approach that harnesses mechanical forces, which is overlooked in current therapeutic strategies. Mechanical forces are pivotal in immune signaling because they impact the activation of key receptors, such as the T cell receptor, chimeric antigen receptor (CAR), and co- receptor PD1. We recently developed force sensitive coiled-coils that can be genetically encoded and inserted into any protein of interest. These coiled-coils change conformation under force and expose reactive residues that can be harnessed for force detection or enzyme recruitment. This project aims to build on our experience to engineer a mechano-transduction platform that will be implemented to enhance CAR T-cell therapies. In aim 1, we will use our force sensors to measure the forces along key immune receptors. In aim 2, we will engineer force transduction modules by combining our force sensors to releasable transcription activators able to induce the expression of any protein of choice, and insert these tools into CARs to enhance CAR T-cell specificity and safety. The successful realization of this project will demonstrate the feasibility and utility of new capabilities to improve the efficacy of CAR-T therapies, extend their application and speed up their development, with high potential impact in cancer immuno-therapies. It will also lay the foundations for new immuno-therapies using different receptors and modes of action.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $211,691 )
2026	2026	YALE UNIV	150 MUNSON ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Cancer Treatment Research	000	2	12/11/2025	NON-COMPETING CONTINUATION	$211,691
														Subtotal = $211,691

Issue Date FY: 2025 ( Subtotal = $195,766 )
2025	2025	YALE UNIV	150 MUNSON ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Cancer Treatment Research	000	1	12/19/2024	NEW	$195,766
														Subtotal = $195,766

Grand Total All Awards = $407,457

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology

Award Number: R21CA294038

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/19/2024

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer